FIELD: medicine. SUBSTANCE: method involves selecting the most promising agents for applying neutron-capturing therapy form gadolinium- and boron- containing compounds. The compounds are mixed with animal tumor cell culture suspensions. Suspension or cell volume is 1.5 ml containing cells in the amount of 107-109/ml. Preparation quantity is to provide 0.3-0.4 mg/ml of boron or 70-90 mg/ml of gadolinium contents. The so produced mixture of gadolinium- and/or boron-containing compounds is irradiated with heat neutrons flow (108-109 heat neutrons/cm2*s) during 30-60 min. Laboratory animals having reinoculated tumors are used as controls. The results as tumor availability and volume in the case group are compared to those observed in a series of control groups composed of animals having reinoculated tumors. EFFECT: accelerated test procedure. 1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD AND DEVICE FOR TREATING MALIGNANT TUMORS BY APPLYING NEUTRON-CATCHING THERAPY | 1998 |
|
RU2141860C1 |
METHOD FOR APPLYING PHOTON-CAPTURING TUMOR THERAPY | 2004 |
|
RU2270045C1 |
METHOD FOR DETERMINING RADIOSENSITIVITY OF TUMORS | 1989 |
|
RU2021833C1 |
MEANS OF SIMULTANEOUS PROTECTIVE ACTION IN RELATION TO HEALTHY ORGANS AND TISSUE AND ADJUVANT ACTION IN RADIO AND CHEMOTHERAPY OF TUMOURS | 2015 |
|
RU2646497C2 |
STRAIN OF MALIGNANT RHABDOMYOSARCOMA PA-23 CELLS IN RAT USED AS A MODEL FOR RESEARCH OF ORGANOTROPIC METASTASIZING PROCESSES AND SCREENING OF ANTITUMOR AGENTS | 1991 |
|
RU2026344C1 |
METHOD FOR PHOTON CAPTURE THERAPY OF TUMOURS | 2013 |
|
RU2533267C1 |
PREPARATION FOR APPLICATION IN PHOTON CAPTURE THERAPY OF MALIGNANT SOLID NEOPLASMS | 2015 |
|
RU2611379C1 |
METHODS FOR COMBINED THERAPY OF MALIGNANT NEOPLASMS USING IRON OXIDE NANOPARTICLES | 2023 |
|
RU2816227C1 |
STIMULATOR OF CYTOKIN AND HEMOPOIETIC FACTORS PRODUCTION AND A METHOD OF ITS USING | 1995 |
|
RU2089179C1 |
GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
Authors
Dates
2000-01-20—Published
1998-02-06—Filed